BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4428113)

  • 21. [Lekozim in the treatment of the vitreoretinal traction syndrome in proliferative diabetic retinopathy].
    Polunin GS; Glukhoded SV; Pirogova EP
    Vestn Oftalmol; 1987; 103(4):41-4. PubMed ID: 3672705
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of synthetic derivatives of Congo red. Angiographic study].
    Zenatti C
    Ann Ocul (Paris); 1971 Mar; 204(3):257-70. PubMed ID: 5089202
    [No Abstract]   [Full Text] [Related]  

  • 23. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
    Zhong H; Guo L
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):56-8. PubMed ID: 9868029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of calcium dobesilate upon thurfyl nicotinate erythema in man.
    Canal P; Erill S
    J Med; 1971; 2(6):375-9. PubMed ID: 5292128
    [No Abstract]   [Full Text] [Related]  

  • 25. Microvascular protection with calcium dobesilate (Doxium) in diabetic retinopathy.
    Freyler H
    Ophthalmologica; 1974; 168(5):400-16. PubMed ID: 4598805
    [No Abstract]   [Full Text] [Related]  

  • 26. Capillary fragility and doxium. A controlled clinical trial.
    Rasch R
    Diabetologia; 1973 Dec; 9(6):483-5. PubMed ID: 4773549
    [No Abstract]   [Full Text] [Related]  

  • 27. [Calcium-dobesilate in chronic crural thrombophlebitis].
    Lawkowicz W; Polubiec A; Domańska B
    Wiad Lek; 1973 Apr; 26(7):599-601. PubMed ID: 4700956
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic value of calcium-dobesilate in hemostatic disorders of the vascular type].
    Lawkowicz W; Polubiec A; Ptaszyński D
    Wiad Lek; 1972 Sep; 25(17):1521-4. PubMed ID: 5076997
    [No Abstract]   [Full Text] [Related]  

  • 29. [The 141 M. D. in odonto-stomatology and oral surgery].
    Donazzan M; Laroche G
    Rev Stomatol Chir Maxillofac; 1966 Dec; 67(12):659-63. PubMed ID: 5297960
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium dobesilate as a treatment for capillary fragility in diabetic retinopathy.
    Benarroch IS; de Salama Benarroch AR; Nano H; Perez H; Bisceglia H
    Ophthalmologica; 1974; 168(5):370-5. PubMed ID: 4832044
    [No Abstract]   [Full Text] [Related]  

  • 31. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
    Klein M; Hirche H
    Klin Monbl Augenheilkd; 1985 Sep; 187(3):195-201. PubMed ID: 3906248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
    Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Capillary resistance and diabetic retinopathy. Effect of Etamsylate (cyclonamine or Dicynone)].
    Sévin R; Cuendet JF
    Ophthalmologica; 1968; 155(3):186-93. PubMed ID: 5652194
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of diabetic retinopathy.
    Einarsdóttir AB; Stefánsson E
    Lancet; 2009 Apr; 373(9672):1316-8. PubMed ID: 19376433
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clofibrate in the treatment of exudative diabetic retinopathy].
    Malcolm J; Lockwood PW; Comhaire E; Malcolm-Thomas B
    Brux Med; 1973 Oct; 53(10):587-90. PubMed ID: 4761152
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 37. Calcium hydroxybenesulfonate improves vascular proliferation in patients with diabetic retinopathy via reducing VEGF, CAM-1 and MMP-9.
    Yao L; Li Y; Zhao Z
    Minerva Med; 2021 Oct; 112(5):668-670. PubMed ID: 32255310
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled clinical trial of calcium dobesylate in the treatment of diabetic retinopathy.
    Daubresse JC; Meunier R; Dumont P
    Diabete Metab; 1977 Mar; 3(1):27-30. PubMed ID: 323086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of conjugated estrogens in diabetic retinopathy].
    Németh L
    Klin Monbl Augenheilkd; 1969 Oct; 155(4):543-8. PubMed ID: 4315571
    [No Abstract]   [Full Text] [Related]  

  • 40. Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
    Javadzadeh A; Ghorbanihaghjo A; Adl FH; Andalib D; Khojasteh-Jafari H; Ghabili K
    Mol Vis; 2013; 19():62-8. PubMed ID: 23335852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.